Palouse Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.46M | Sell |
|
|||||
|
2025
Q2 | $1.42M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $1.06M | Buy |
|
|||||
|
2023
Q2 | $927K | Sell |
|
|||||
|
2023
Q1 | $1.12M | Sell |
|
|||||
|
2022
Q4 | $99.6M | Sell |
|
|||||
|
2022
Q3 | $1.59M | Sell |
|
|||||
|
2022
Q2 | $1.41M | Sell |
|
|||||
|
2022
Q1 | $2.08M | Sell |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $1.58M | Sell |
|
|||||
|
2021
Q2 | $2.08M | Buy |
|
|||||
|
2021
Q1 | $1.74M | Buy |
|